Crystal structure of multi-drug resistant hiv-1 protease pr-s17 with a substrate analog p2-nc in p61 Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2019-03-01 Method: X-RAY DIFFRACTION Resolution: 1.67 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6O5A_A , 6O5A_B
Crystal structure of multi-drug resistant hiv-1 protease pr-s17 with substrate analog ca-p2 Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2019-03-04 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6O5X_A , 6O5X_B , 6O5X_C , 6O5X_D
Hiv-1 protease triple mutants v32i, i47v, v82i with grl-011-11a (a methylamine bis-tetrahydrofuran p2-ligand, sulfonamide isostere derivate) Deposition Author(s): Pawar, S. , Wang, Y.-F. , Weber, I.T.
Date: 2019-05-03 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6OTG_A , 6OTG_B
Hiv-1 wild type protease with grl-00819a, with phenyl-boronic-acid as p2'-ligand and with a 6-5-5-ring fused crown-like tetrahydropyranofuran as the p2-ligand Deposition Author(s): Kneller, D.W. , Wang, Y.-F. , Weber, I.T.
Date: 2019-09-03 Method: X-RAY DIFFRACTION Resolution: 1.33 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6U7O_A , 6U7O_B
Hiv-1 wild type protease with grl-03119a, with phenyl-boronic-acid as p2'-ligand and with a hexahydro-4h-furo-pyran as the p2-ligand Deposition Author(s): Kneller, D.W. , Wang, Y.-F. , Weber, I.T.
Date: 2019-09-03 Method: X-RAY DIFFRACTION Resolution: 1.13 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6U7P_A , 6U7P_B
Hiv-1 wild type protease with grl-026-18a, a crown-like tetrahydropyranotetrahydrofuran with a bridged methylene group as a p2 ligand Deposition Author(s): Kneller, D.W. , Wang, Y.-F. , Weber, I.T.
Date: 2019-12-20 Method: X-RAY DIFFRACTION Resolution: 1.18 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6VCE_A , 6VCE_B
Hiv-1 wild type protease with grl-052-16a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2020-01-30 Method: X-RAY DIFFRACTION Resolution: 1.25 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6VOD_A , 6VOD_B
Hiv-1 wild type protease with grl-019-17a, a tricyclic cyclohexane fused tetrahydrofuranofuran (chf-thf) derivative as the p2 ligand and a aminobenzothiazole(abt)-based p2'-ligand Deposition Author(s): Agniswamy, J. , Wang, Y.-F. , Weber, I.T.
Date: 2020-01-30 Method: X-RAY DIFFRACTION Resolution: 1.3 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 6VOE_A , 6VOE_B
Crystal structure of inhibitor-free hiv-1 prs17 revertant mutant prs17 v48g Deposition Author(s): Burnaman, S.H. , Wang, Y.-F. , Weber, I.T.
Date: 2021-06-09 Method: X-RAY DIFFRACTION Resolution: 1.32 Å Organism(s): Human Immunodeficiency Virus Type 1 Group M Subtype B (Isolate Bru/Lai) Sequences Data: 7N6T_A , 7N6T_B
Crystal structure of hiv-1 protease multiple mutants prs17 with revertant mutation v48g bound to inhibitor amprenavir Deposition Author(s): Burnaman, S.H. , Wang, Y.-F. , Weber, I.T.
Date: 2021-06-09 Method: X-RAY DIFFRACTION Resolution: 1.39 Å Organism(s): Human Immunodeficiency Virus Type 1 Group M Subtype B (Isolate Bru/Lai) Sequences Data: 7N6V_A , 7N6V_B